HI-Light Vitiligo Trial

  • Research type

    Research Study

  • Full title

    Home Interventions and Light therapy for the treatment of vitiligo

  • IRAS ID

    162392

  • Contact name

    Jonathan Batchelor

  • Contact email

    jonathan.batchelor@nottingham.ac.uk

  • Eudract number

    2014-003473-42

  • Duration of Study in the UK

    4 years, 2 months, 31 days

  • Research summary

    Vitiligo causes loss of pigment on the skin and white patches appear in the affected areas. This condition affects around 1% of the population worldwide, and patients with vitiligo can experience problems such as shame, depression, and low self-esteem due to the appearance of their skin.

    There is no cure for vitiligo, as the cause of the condition is not understood. Small patches of vitiligo are usually treated with topical steroid ointments. Ultraviolet B light therapy (also known as NB-UVB) is also sometimes offered as a treatment, but it involves frequent visits to hospital and is mainly for large areas when vitiligo is more widespread. Hand-held NB-UVB light units are available to use in the home on small patches of vitiligo. However, these units are not available on the NHS. There is not a lot of information about how well steroid creams and light therapy work to improve the appearance of vitiligo. and we do not know whether they would work, or work better, together. The HI-Light trial has been designed to test these two commonly used treatments: topical steroid ointment and NB-UVB light therapy. The trial aims to find out more information about how well the treatments work, and to find out if they work, or work better, when used together.

    This study will recruit 440 adults and children over the age of 5 across the UK who have non-segmental vitiligo, and at least one patch of vitiligo which has appeared or gotten larger in the past 12 months. Participants will be asked to treat their vitiligo patches with ointment and a light therapy unit, at home, for a period of 9 months. Understanding more about how well these treatments work to improve the appearance of vitiligo could help to improve future care for patients with vitiligo.

  • REC name

    East Midlands - Derby Research Ethics Committee

  • REC reference

    14/EM/1173

  • Date of REC Opinion

    27 Oct 2014

  • REC opinion

    Further Information Favourable Opinion